Edition:
United Kingdom

IPCA Laboratories Ltd (IPCA.NS)

IPCA.NS on National Stock Exchange of India

661.45INR
10:29am GMT
Change (% chg)

Rs21.40 (+3.34%)
Prev Close
Rs640.05
Open
Rs642.00
Day's High
Rs676.90
Day's Low
Rs638.05
Volume
764,399
Avg. Vol
270,746
52-wk High
Rs676.90
52-wk Low
Rs400.00

Chart for

About

Ipca Laboratories Limited is engaged in pharmaceuticals business. The Company is a manufacturer and supplier of over 10 active pharmaceutical ingredients (APIs). It offers APIs, such as atenolol, hydroxychloroquine sulfate, morantel citrate, pyrantel pamoate and zaltoprofen. It offers brands, such as Zerodol, Lariago, HCQS... (more)

Overall

Beta: -0.18
Market Cap(Mil.): Rs65,743.43
Shares Outstanding(Mil.): 126.20
Dividend: 1.00
Yield (%): 0.19

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.60
EPS (TTM): -- -- --
ROI: -- 14.90 10.66
ROE: -- 16.41 14.30

BRIEF-India's IPCA Labs Dec-Qtr Profit More Than Doubles

* DEC QUARTER PROFIT FROM CONTINUING OPERATIONS 1.06 BILLION RUPEES VERSUS PROFIT 413.8 MILLION RUPEES YEAR AGO

07 Feb 2018

BRIEF-Ipca Laboratories' Units To Acquire Pisgah Labs For $9.65 Mln​​

* SAYS ‍ACQUISITION OF 100 PCT SHARE CAPITAL OF PISGAH LABS INC., NORTH CAROLINA, USA BY COMPANY'S SUBSIDIARIES

17 Jan 2018

BRIEF-India's IPCA Labs Sept-qtr profit up about 76 pct

* Sept quarter profit from continuing operations 964.7 million rupees versus profit of 549.5 million rupees last year

14 Nov 2017

BRIEF-Ipca Labs says The ‍global Fund selected co as panel supplier of anti-malarial medicines

* The ‍global Fund selected co as panel supplier of anti-malarial medicines Source text - http://bit.ly/2zwhueB Further company coverage:

10 Nov 2017

Earnings vs. Estimates